Market Research Logo

Global Microfluidic Market for Healthcare Application 2016-2020

About Microfluidics technology

Microfluidics technology deals with the research and development of micro-scale devices, which are capable of handling small amounts of fluids. These devices are used in the healthcare sector to dispense the exact volume of fluids for research, drug development, and drug delivery. Microfluidic devices can also be used to monitor patient health status, ensuring early detection and treatment of diseases. The advantages of these devices are their compact size, low power consumption, cost efficiency, and high functionality.

Technavio’s analysts forecast the global microfluidic market for healthcare application to grow at a CAGR of 17.59% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global microfluidic market for healthcare application for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales and use of microfluidic devices and technology.The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Microfluidic Market for Healthcare Application 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Laboratories
  • Agilent Technologies
  • Becton Dickinson and Company
  • Bio-Rad Laboratories
  • RainDance Technologies
  • Roche Diagnostics
  • Siemens Healthcare GmbH
Other prominent vendors
  • Biocartis
  • Biofluidix
  • Cepheid
  • Danaher
  • Fluidigm
  • Great Basin
  • Life Technologies
  • Oxford Nanopore
  • PerkinElmer
  • Tear Lab
  • Thermo Fisher Scientific
Market driver
  • Rapid increase in elderly population and age-related diseases
  • For a full, detailed list, view our report
Market challenge
  • Low margins for companies in the microfluidic value chain
  • For a full, detailed list, view our report
Market trend
  • Use of paper-based microfluidic devices
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Microfluidic Market for Healthcare Application 2016-2020

Technavio recognizes the following companies as the key players in the global microfluidic market for healthcare application: Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio Rad Laboratories, RainDance Technologies, Roche Diagnostics, and Siemens Healthcare GmbH.

Other Prominent Vendors in the market are: Biocartis, Biofluidix, Cepheid, Danaher, Fluidigm, Great Basin, Life Technologies, Oxford Nanopore, PerkinElmer, Tear Lab, and Thermo Fisher Scientific.

Commenting on the report, an analyst from Technavio’s team said: “The growing use of paper-based microfluidic devices will be a major trend for market growth. The future generation of microfluidics diagnostics will focus on producing these devices from paper. As of 2015, extensive research is being carried out in this direction. Paper-based microfluidic devices will use hydrophobic channel walls printed on paper. These hydrophobic walls will ensure that the speed and flow direction of the liquid is controlled. The use of paper to make such devices will reduce the cost of these devices drastically, along with making them very easy to dispose of. In 2015, this paper-based technique was limited to devices, which have simple designs. However, the use of this technique will have a considerable impact on the microfluidic market in the forecast period.”

According to the report, growth in lifestyle diseases will be the key driver for market growth. The growth of lifestyle-related diseases is having an adverse impact on life expectancy on a global scale. According to World Health Organization (WHO), non-communicable diseases are the leading cause of mortality worldwide, especially in the developing nations. Lifestyle-related diseases are associated mainly with the excessive use of tobacco, harmful use of alcohol, and poor diet. WHO has warned that public policies are required to prevent these lifestyle-related diseases and reduce the effect of these factors on the health of individuals, as they lead to high blood pressure, high cholesterol levels, and high incidence of diabetes.

Further, the report states that reliability issues will be a major challenge for the market. Microfluidic devices have to be assembled, integrated, and packaged before use. Although the system components are reliable, poor assembly can affect the reliability of the system. In order for these devices to be reliable, the components connected to the device must endure high pressure, offer protection in harsh environments, and allow fluid input. If the device is not airtight, it may result in sensor contamination, delamination, cracks, leakage, fractures, and embrittlement. At the time of inserting the fluid into the device, the fluidic pathways, as well as the optical and electronic ones, have to be aligned; else the device will not function properly.

Companies Mentioned

Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio Rad Laboratories, RainDance Technologies, Roche Diagnostics, Siemens Healthcare GmbH.Biocartis, Biofluidix, Cepheid, Danaher, Fluidigm, Great Basin, Life Technologies, Oxford Nanopore, PerkinElmer, Tear Lab, Thermo Fisher Scientific.

  • Executive summary
    • Highlights
  • Scope of the report
    • Report overview
    • Key vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Technology landscape
    • Microfluidic systems
      • Table Steps of a typical microfluidic process
  • Market landscape
    • Industry overview
      • Table Market segmentation of microfluidics in healthcare
    • Market size and forecast
      • Table Global microfluidic market for healthcare application 2016-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by application
    • End-user applications of microfluidics in healthcare 2015
      • Table Percentage segregation of microfluidics for application in healthcare sector 2015
    • End-user applications of microfluidics in healthcare 2020
      • Table Percentage segregation of microfluidics for application in healthcare sector 2020
    • In-vitro diagnostics using microfluidics
      • Table Global microfluidic market for in-vitro diagnostics in healthcare 2015-2020 ($ billions)
    • Pharmaceutical research using microfluidics
      • Table Global microfluidic market in pharmaceutical research for healthcare 2015-2020 ($ billions)
    • Drug delivery devices using microfluidics
      • Table Global microfluidic market in drug delivery devices for healthcare 2015-2020 ($ millions)
  • Geographical segmentation
    • Regional segregation 2015
      • Table Geographical share in percentage 2015
    • Regional segregation 2020
      • Table Geographical share in percentage 2020
    • Americas
      • Table Global microfluidic market for healthcare application in Americas 2016-2020 ($ billions)
    • EMEA
      • Table Global microfluidic market for healthcare application in EMEA 2015-2020 ($ billions)
    • APAC
      • Table Global microfluidic market for healthcare application in APAC 2015-2020 ($ millions)
  • Market drivers
    • Compact size of microfluidic devices
    • Growth in lifestyle diseases
    • Increase in research funding and government participation
    • Rapid increase in elderly population and age-related diseases
    • Higher throughput and reduced reaction cost
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High penetration of traditional healthcare equipment
    • Low margins for companies in the microfluidic value chain
    • Lack of awareness about microfluidics
    • Reliability issues
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Use of paper-based microfluidic devices
    • Growth in POC testing
  • Vendor landscape
    • Competitive scenario
      • Table Overview of major players in the global microfluidic market for healthcare application 2015
  • Key vendors
    • Abbott Laboratories
      • Table Recent developments: Abbott Laboratories
    • Agilent Technologies
      • Table Sector performance
    • Becton Dickinson
      • Table Capital expenditure
    • Bio-Rad Laboratories
      • Table Segment performance
      • Table Capital expenditure
    • RainDance Technologies
    • Roche Diagnostics
    • Siemens Healthcare
      • Table Siemens Healthcare: Business segmentation
      • Table Recent developments: Siemens Healthcare
    • Other prominent vendors
      • Table Other prominent vendors
  • Key recommendation s for vendors and investors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report